Private Advisor Group, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1567755
MORRISTOWN, NJ
Position in REGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$13,378,261
-$336,325 QoQ
Shares Held
17,315
-2.5% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Mar 31, 2026CallValue
$463,584
CallShares
600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $54,115,412 across 44 Biotechnology names. REGN ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
17,315 | $13,378,261 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,648,556 | $12,644,424 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
106,662 | $5,073,911 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,433 | $3,765,671 | |
| 5 | CRMD |
CorMedix Inc.
|
504,668 | $3,426,695 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
174,415 | $1,669,151 | |
| 7 | AVXL |
Anavex Life Sciences Corp.
|
499,700 | $1,534,079 | |
| 8 | CDXS |
Codexis, Inc.
|
847,001 | $1,380,611 |
All Filings in REGN
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,378,261 | 17,315 | Shares | Sole | 2026-04-27 | |
| 2026-03-31 | $463,584 | 600 | Call | Sole | 2026-04-27 | |
| 2025-12-31 | $13,714,586 | 17,768 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $617,496 | 800 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $955,859 | 1,700 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $12,269,855 | 21,822 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,075,275 | 19,191 | Shares | Sole | 2025-08-11 | |
| 2025-06-30 | $525,000 | 1,000 | Call | Sole | 2025-08-11 | |
| 2025-03-31 | $9,054,267 | 14,276 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $8,775,193 | 12,319 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $5,635,697 | 5,361 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $5,316,109 | 5,058 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,527,552 | 4,704 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $4,289,568 | 4,884 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,067,068 | 4,942 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,037,987 | 4,228 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,146,174 | 3,829 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,609,629 | 3,617 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $2,555,707 | 3,710 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,052,196 | 6,855 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $5,886,283 | 8,428 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,499,300 | 11,875 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $12,312,992 | 20,346 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $9,717,478 | 17,398 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $7,429,717 | 15,703 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $5,051,881 | 10,457 | Shares | Sole | 2021-04-01 | |
| 2020-12-31 | $96,622 | 200 | Call | Sole | 2021-04-01 | |
| 2020-09-30 | $5,160,052 | 9,218 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $4,397,356 | 7,051 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,827,687 | 5,791 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||